Stelara and Diet Trial for Crohn"s Disease

Summary

Dietary therapy involving the Crohn's disease exclusion diet (CDED) is an evolving strategy to target the microbiome and innate immunity in order to reduce inflammation and promote healing. The goal of the current pilot study is to evaluate the added benefit of treatment with Ustekinumab combined with CDED in anti TNF exposed patients compared to treatment with Ustekinumab alone in term of achieving remission.

Timeline

Start

2022-01

Primary completion

2025-01

Completion

2026-01

Drugs

Indications